Health
Oxford-AstraZeneca vaccine shows promise in elderly, trial results by Christmas – ABC News
AstraZeneca and Oxford University’s potential COVID-19 vaccine produces a strong immune response in those aged over 70.
Oxford University and AstraZeneca’s potential COVID-19 vaccine produced a strong immune response in older adults, newly published data has showed, with researchers expecting to release late-stage trial results by Christmas.
Key points:
- Late stage Oxford-AstraZeneca trials have shown it develops antibody and T-cell responses in elderly patients
- Rival drugmakers Pfizer-BioNTech and Moderna have recently pushed ahead in the race for a COVID vaccine
- Researchers report no serious side effects from the…
Continue Reading
-
Noosa News12 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News13 hours agoMotorcyclist dies in crash with truck
-
Noosa News14 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General19 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging